Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5
Tobias J Buscham,
Maria A Eichel-Vogel,
Anna M Steyer,
Olaf Jahn,
Nicola Strenzke,
Rakshit Dardawal,
Tor R Memhave,
Sophie B Siems,
Christina Müller,
Martin Meschkat,
Ting Sun,
Torben Ruhwedel,
Wiebke Möbius,
Eva-Maria Krämer-Albers,
Susann Boretius,
Klaus-Armin Nave,
Hauke B Werner
Affiliations
Tobias J Buscham
Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany
Maria A Eichel-Vogel
Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany
Anna M Steyer
Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany; Electron Microscopy Core Unit, Max Planck Institute of Experimental Medicine, Göttingen, Germany
Proteomics Group, Max Planck Institute of Experimental Medicine, Göttingen, Germany; Translational Neuroproteomics Group, Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Georg-August-University, Göttingen, Germany
Institute for Auditory Neuroscience, University Medicine Göttingen, Göttingen, Germany
Rakshit Dardawal
Functional Imaging Laboratory, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany
Tor R Memhave
Functional Imaging Laboratory, German Primate Center, Leibniz Institute for Primate Research, Göttingen, Germany
Sophie B Siems
Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany
Christina Müller
Institute of Developmental Biology and Neurobiology, Johannes Gutenberg University, Mainz, Germany
Martin Meschkat
Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany; Abberior Instruments Gmbh, Göttingen, Germany
Ting Sun
Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany
Torben Ruhwedel
Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany; Electron Microscopy Core Unit, Max Planck Institute of Experimental Medicine, Göttingen, Germany
Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany; Electron Microscopy Core Unit, Max Planck Institute of Experimental Medicine, Göttingen, Germany
Eva-Maria Krämer-Albers
Institute of Developmental Biology and Neurobiology, Johannes Gutenberg University, Mainz, Germany
Oligodendrocytes facilitate rapid impulse propagation along the axons they myelinate and support their long-term integrity. However, the functional relevance of many myelin proteins has remained unknown. Here, we find that expression of the tetraspan-transmembrane protein CMTM5 (chemokine-like factor-like MARVEL-transmembrane domain containing protein 5) is highly enriched in oligodendrocytes and central nervous system (CNS) myelin. Genetic disruption of the Cmtm5 gene in oligodendrocytes of mice does not impair the development or ultrastructure of CNS myelin. However, oligodendroglial Cmtm5 deficiency causes an early-onset progressive axonopathy, which we also observe in global and tamoxifen-induced oligodendroglial Cmtm5 mutants. Presence of the WldS mutation ameliorates the axonopathy, implying a Wallerian degeneration-like pathomechanism. These results indicate that CMTM5 is involved in the function of oligodendrocytes to maintain axonal integrity rather than myelin biogenesis.